Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioTech Medics has closed on the $1.25 million acquisition of five FHJ Scientific Inc's five US letters of patent and related foreign patents covering a novel compound solution.
Subscribe to our email newsletter
The patents cover FHJ Scientific’s proprietary SHBAN compound solution. Scientific evidence and studies by top medical institutions suggest the unique solution may be used in a variety of ways such as aiding the healing of gingivitis or gum disease, wound healing, antiseptic nasal spray, sunburn and burn healing, psoriasis, fungal infections such as athletes foot, eye infections and cuts or abrasions.
BioTech Medics (BTMD) intends to soon announce the addition of a new advisory board member to assist in making application for medical research grants for further development of the SHBAN compound solution.
“The asset acquisition is a major accomplishment for BTMD and part of our long-term planning. BTMD was able to acquire the patents, which have over 15 years of R&D, for stock in BTMD,” said Keith Houser, the company’s CEO.